Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Deep Brain Stimulation In Parkinson’s Disease Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological Advancements In Deep Brain Stimulation Devices
3.2.1.2. Increasing Prevalence Of Parkinson’s Disease
3.2.1.3. Government Funding For Research And Development
3.2.2. Market Restraint Analysis
3.2.2.1. Complex Regulatory Framework
3.2.2.2. Risk And Complications Associated With DBS Surgery
3.2.3. Market Opportunities Analysis
3.2.3.1. Increasing Clinical Studies On DBS Assessments For Parkinson's Disease
3.2.4. Market Challenge Analysis
3.2.4.1. Alternatives For DBS System
3.3. U.S. Deep Brain Stimulation In Parkinson’s Disease Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Deep Brain Stimulation In Parkinson’s Disease Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Deep Brain Stimulation In Parkinson’s Disease Market Movement Analysis
4.3. U.S. Deep Brain Stimulation In Parkinson’s Disease Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Single-Channel
4.4.1. Single-Channel U.S. Deep Brain Stimulation In Parkinson’s Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Dual-Channel
4.5.1. Dual-Channel U.S. Deep Brain Stimulation In Parkinson’s Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Market Participant Categorization
5.2. Key Company Profiles
5.2.1. ABBOTT
5.2.1.1. Company Overview
5.2.1.2. Financial Performance
5.2.1.3. Service Benchmarking
5.2.1.4. Strategic Initiatives
5.2.2. Medtronic
5.2.2.1. Company Overview
5.2.2.2. Financial Performance
5.2.2.3. Service Benchmarking
5.2.2.4. Strategic Initiatives
5.2.3. Boston Scientific Corporation
5.2.3.1. Company Overview
5.2.3.2. Financial Performance
5.2.3.3. Service Benchmarking
5.2.3.4. Strategic Initiatives
5.3. Heat Map Analysis/ Company Market Position Analysis
5.4. Estimated Company Market Share Analysis, 2023
5.5. List of Other Key Market Players
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Deep Brain Stimulation In Parkinson’s Disease Market, by Product, 2018 - 2030 (USD Million)
Table 4. Participant’s Overview
Table 5. Financial Performance
Table 6. Product Benchmarking
Table 7. Strategic Initiatives
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 U.S. Deep Brain Stimulation In Parkinson’s Disease Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Product Marketplace: Key Takeaways
Fig. 14 U.S. Deep Brain Stimulation In Parkinson’s Disease Market, for Single-channel, 2018 - 2030 (USD Million)
Fig. 15 U.S. Deep Brain Stimulation In Parkinson’s Disease Market, for Dual-channel, 2018 - 2030 (USD Million)